DoD Reconstructive Transplant, Investigator- Initiated Research Award | W81XWH 22 RTRP IIRA

Opportunity Information: Apply for W81XWH 22 RTRP IIRA

The DoD Reconstructive Transplant, Investigator-Initiated Research Award (FY22 RTRP IIRA; Funding Opportunity Number W81XWH 22 RTRP IIRA) is a Department of Defense research funding opportunity administered through the U.S. Army Medical Research Acquisition Activity (USAMRAA). It is designed to back investigator-driven studies that can meaningfully advance reconstructive transplantation research, improve clinical care, and ultimately enhance patient quality of life. While the program explicitly welcomes innovative, potentially groundbreaking ideas, it places equal weight on strong scientific justification and a clear line of sight to real-world usefulness, particularly for populations connected to military service.

A core expectation of the award is a well-developed study design that is rigorous, feasible, and built for reproducibility. Applicants are expected to describe their approach clearly and in enough detail to demonstrate that the work can be carried out successfully and that results will be reliable and interpretable. Where appropriate, proposals should include a statistical analysis plan and power calculations, reflecting an emphasis on sound methodology and credible outcomes. In addition to being scientifically solid, projects should show translational feasibility, meaning the work should plausibly move the field forward toward practical tools, clinical protocols, or actionable biological insights rather than remaining purely conceptual.

The opportunity also emphasizes impact in both the short and long term. Applicants need to explain what their research will change or enable, and why that change matters to reconstructive transplantation. Importantly, projects must align with at least one of the FY22 RTRP IIRA Focus Areas (the notice references these focus areas as required targets, though they are not listed in the provided excerpt). In practical terms, reviewers are looking for research that fits the program priorities, addresses meaningful gaps, and has a clear potential to shift current understanding or practice in reconstructive transplant science and care.

Military relevance is a non-negotiable requirement. Proposed work must be responsive to the healthcare needs of military Service Members and/or Veterans recovering from traumatic injury, as well as potentially benefiting their families, caregivers, and clinicians, and by extension the broader public. The opportunity encourages collaboration with military researchers and clinicians, recognizing that such partnerships can strengthen relevance and access to real-world clinical context, but collaboration is not mandatory. The key requirement is that the proposal convincingly ties the research question and expected outcomes to problems faced in military and Veteran health contexts, especially those arising from traumatic injuries where reconstructive transplantation may play a role.

Another major requirement is the inclusion of preliminary or supporting evidence. The program allows flexibility in what counts as the foundation for a research idea: motivating observations can come from laboratory discoveries, population-based analyses, clinical experience, or even anecdotal insights. However, the application must include preliminary and/or published data relevant to reconstructive transplantation that supports the project rationale. This reflects the program's balance between welcoming innovation and ensuring that proposals are anchored in evidence that makes the project plausible and reviewable.

In terms of scientific scope, the IIRA mechanism is broad and can support work across the research pipeline from basic to translational. That includes preclinical studies (such as animal models), research involving human subjects, studies using human anatomical substances, and correlative or ancillary studies linked to an existing clinical trial. This flexibility allows applicants to propose anything from foundational mechanistic work (for example, immune tolerance, graft integration, or tissue regeneration questions) to applied studies that directly inform clinical decision-making, monitoring, or functional outcomes, as long as the work remains within reconstructive transplantation and meets the program's standards for rigor, relevance, and impact.

Administrative details from the notice indicate the opportunity is categorized as discretionary and supports awards via grant and cooperative agreement mechanisms under CFDA 12.420 (Science and Technology and other Research and Development). Eligibility is described as unrestricted, meaning it is broadly open to different entity types unless additional eligibility clarifications apply elsewhere in the full announcement. The posting lists an expected number of awards of three, with an award ceiling shown as 0 (often a placeholder in summary records, with actual funding limits typically specified in the full funding announcement). The opportunity was created June 14, 2022, and the original closing date was October 19, 2022.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Reconstructive Transplant, Investigator- Initiated Research Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Jun 14, 2022.
• Applicants must submit their applications by Oct 19, 2022. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 3 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 22 RTRP IIRA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: